Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Azithromycin impurity 4 is a characterized impurity of the antibiotic Azithromycin. This compound may serve as a reference standard for analytical testing and quality control in pharmaceutical research and development. It is utilized in studies that assess the purity and stability of Azithromycin formulations, ensuring compliance with regulatory standards. -
Drug Impurity
Naproxen impurity 2 is a known impurity associated with the anti-inflammatory drug Naproxen. This compound is essential for analytical applications, including method development and validation in pharmacokinetic studies. Its identification and quantification are critical for ensuring the quality and safety of pharmaceutical formulations containing Naproxen. -
Drug Impurity
Telmisartan impurity 11 is a chemical impurity associated with the drug Telmisartan, which primarily targets the angiotensin II receptor. This impurity is crucial for quality control in pharmaceutical formulations and is employed to assess the purity and stability of Telmisartan during analysis. It serves as an important reference standard in drug development and regulatory compliance, aiding in the evaluation of related substance profiles and impurity thresholds. -
Drug Impurity
Roxithromycin Ep impurity E is a known impurity of the antibiotic Roxithromycin, serving as an important reference compound in chemical research. Its characterization is critical for ensuring the purity and safety of Roxithromycin formulations. Researchers utilize this impurity in stability studies and quality control assessments to adhere to pharmaceutical regulatory standards. -
Drug Impurity
Leflunomide impurity 5 is a known impurity of Leflunomide, a disease-modifying antirheumatic drug (DMARD). This compound is primarily used in the evaluation of drug purity and quality control in pharmaceutical research. Its presence must be monitored during the development and manufacturing processes to ensure compliance with safety and efficacy standards. -
Drug Impurity
Etoricoxib impurity 26 is a detected impurity associated with the non-steroidal anti-inflammatory drug Etoricoxib. It serves as a valuable reference compound for quality control and analytical studies in pharmaceutical research. This impurity can be utilized to investigate the stability, pharmacokinetics, and metabolic profile of Etoricoxib in various formulations. Understanding such impurities is critical for ensuring the safety and efficacy of pharmaceutical compounds. -
Drug Impurity
Glipizide impurity 10 is a known impurity of the antidiabetic agent Glipizide, primarily affecting its pharmacological profile. This compound is utilized in analytical and quality control settings to assess the purity of Glipizide formulations. Its presence can impact the efficacy and safety of Glipizide in therapeutic applications, making it an important analyte for pharmaceutical research and development. -
Drug Impurity
Citalopram impurity 2 hydrochloride, also known as (rac)-Didemethyl citalopram hydrochloride, is an identified impurity of Citalopram hydrochloride. This compound is utilized in analytical research for the characterization and quality control of Citalopram formulations. Understanding its presence in pharmaceutical formulations helps in ensuring the integrity and safety of drug products. -
Drug Impurity
Haloperidol impurity 1 hydrochloride is a chemical impurity associated with Haloperidol hydrochloride. This compound plays a crucial role in analytical research, particularly in the evaluation of drug purity and quality control within pharmaceutical formulations. Its characterization may aid in understanding the stability and efficacy of Haloperidol-based therapies, making it valuable for researchers in the field of medicinal chemistry. -
Drug Impurity
Testosterone impurity 9 is a chemical byproduct associated with Testosterone synthesis. As a drug impurity, it serves as an important analytical reference for quality control in pharmaceutical formulations. Its identification and quantification are essential for ensuring the purity and efficacy of Testosterone-containing products in research and development settings. -
Drug Impurity
Raloxifene impurity 5 is a chemical impurity associated with Raloxifene, a selective estrogen receptor modulator. This impurity is essential in the analysis and characterization of Raloxifene, particularly in assessing the purity and quality of pharmaceutical formulations. It serves as a reference standard in drug development and regulatory submissions, ensuring compliance with safety and efficacy guidelines. -
Drug Impurity
Lamivudine impurity 1 is identified as a chemical impurity associated with the antiviral agent Lamivudine. This compound serves as a critical reference standard for analytical purposes in pharmaceutical research and quality control. Its study is essential for evaluating the purity of Lamivudine formulations and ensuring compliance with industry standards. -
Drug Impurity
Dicyclomine impurity 1 is identified as an impurity associated with Dicyclomine, a medication primarily used as an antispasmodic. This compound is of significance in pharmaceutical research and quality control, serving as a reference standard for evaluating drug purity and stability. Its characterization is critical for ensuring the safety and efficacy of Dicyclomine formulations in clinical applications. -
Drug Impurity
Salbutamol impurity 15 is a chemical impurity related to the asthmatic treatment agent Salbutamol. It serves as a critical reference standard for the analysis of Salbutamol formulations and assessments of drug quality. This compound is vital for understanding the stability and purity of Salbutamol during pharmaceutical development and quality control processes. -
Drug Impurity
Rivastigmine impurity 10 is a chemical impurity associated with the acetylcholinesterase inhibitor, Rivastigmine. This compound is primarily used for quality control and analytical purposes in pharmaceutical research. It is important for assessing the purity of Rivastigmine in formulations and ensuring compliance with regulatory standards. -
Drug Impurity
Trimetazidine impurity 7 is a chemical impurity associated with Trimetazidine, a drug commonly used in cardiovascular therapy. Its presence may be relevant for analytical and quality control studies in pharmaceutical development. This impurity can serve as a reference standard for the assessment of drug purity and stability, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Glipizide impurity 12 is a chemical impurity associated with Glipizide, a medication commonly used to manage type 2 diabetes. It serves as a reference standard in pharmaceutical research and quality control, aiding in the assessment of drug purity and stability. This compound is essential for ensuring compliance with regulatory standards and for conducting analytical methods related to Glipizide formulations. -
Drug Impurity
Hydroquinone Impurity 1 is a chemical impurity associated with Hydroquinone, primarily identified in pharmaceutical formulations. Its presence may impact drug efficacy and safety profiles, making it significant in quality control and analytical chemistry. Research applications include assessing drug purity and evaluating the stability of Hydroquinone-containing compounds. -
Drug Intermediate
Ethyl 4-methyl-2-(2-thienyl)-thiazole-5 carboxylate is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its unique thiazole and thienyl structure make it a valuable building block for the development of various pharmacologically active compounds. This reagent is essential for researchers exploring novel drug formulations and mechanisms of action in drug discovery. -
Drug Impurity
Dacomitinib impurity 8 is a chemical impurity associated with the pharmacological compound Dacomitinib, a targeted therapy for non-small cell lung cancer. This impurity can be utilized in analytical research to assess the purity and stability of Dacomitinib formulations. Understanding such impurities is critical for ensuring the quality and efficacy of therapeutic agents in drug development. -
Drug Impurity
Plesafo impurity 2 is identified as a drug impurity associated with Plesafo. This compound serves as a critical reference standard for analytical applications, including method validation and quality control in pharmaceutical development. Its characterization is essential for assessing the purity and safety profiles of drug formulations containing Plesafo. -
Drug Impurity
Mycophenolate impurity 2 is a chemical byproduct associated with the synthesis of Mycophenolate. As a drug impurity, it serves as an important reference standard in analytical chemistry for the evaluation of purity and stability in pharmaceutical formulations. It is commonly utilized in research applications focused on drug development and quality control testing to ensure the integrity and safety of Mycophenolate-containing products. -
Drug Impurity
Atorvastatin impurity 5 is a known impurity associated with the cholesterol-lowering agent Atorvastatin. This compound can be utilized for quality control and analytical studies in pharmaceutical research, particularly in the assessment of drug purity and stability. Its identification and quantification are essential for ensuring the efficacy and safety of Atorvastatin formulations. -
Drug Impurity
Aripiprazole impurity 11 is a chemical impurity associated with the antipsychotic agent Aripiprazole. This compound serves as an essential reference standard for the evaluation of drug purity and quality control in pharmaceutical research. Its characterization is crucial for assessing the safety and efficacy of Aripiprazole formulations. -
Drug Impurity
Sofosbuvir impurity 2 is a characterized impurity of Sofosbuvir, a nucleotide analog antiviral agent targeting the hepatitis C virus. This impurity serves as a crucial reference standard for quality control and stability studies in pharmaceutical research and development. Its identification and quantification are essential for ensuring the integrity of Sofosbuvir formulations. -
Drug Impurity
Fluphenazine decanoate impurity 10 is a chemical impurity associated with Fluphenazine decanoate. This compound is primarily utilized in the quality control and characterization of pharmaceutical formulations, as it provides insight into the purity and stability of the parent drug. Research applications may include studies on drug metabolism, efficacy, and safety in the context of antipsychotic therapy. -
Drug Impurity
Tamsulosin impurity 7 is a known impurity associated with the pharmaceutical agent Tamsulosin, a selective α1-adrenergic antagonist. This compound is utilized primarily in the analysis of drug purity and stability within pharmaceutical research. Its presence can be important for understanding the quality control and regulatory compliance of Tamsulosin formulations. -
Drug Impurity
Mebendazole Impurity 1, also known as 1-Methylpiperazine 1-oxide, is a chemical impurity associated with Mebendazole. This compound is relevant in ensuring the quality and safety of pharmaceutical formulations containing Mebendazole. Its analysis and characterization are essential in drug development and quality control processes within pharmaceutical research. -
Drug Impurity
Abiraterone Impurity 10 is a chemical impurity associated with the drug Abiraterone, which works by inhibiting the enzyme CYP17A1, thereby reducing androgen production. This compound serves as a crucial reference material for quality control and analytical validation in pharmaceutical research. Its characterization is essential for ensuring the purity and efficacy of Abiraterone formulations in clinical applications. -
Drug Impurity
Clarithromycin impurity 9 is a known impurity associated with the antibiotic clarithromycin. This compound is primarily utilized in analytical chemistry for the identification and quantification of drug impurities in pharmaceutical formulations. Research applications include the assessment of drug quality and the evaluation of metabolic pathways in drug development. -
Drug Impurity
Haloperidol impurity 4, also known as Haloperidol impurity E, is a chemical impurity associated with Haloperidol. It serves as a crucial reference standard for quality control and analytical studies in pharmaceutical research. The identification and characterization of this impurity are important for ensuring the purity and safety of Haloperidol formulations in drug development and pharmacokinetic studies. -
Drug Intermediate
4-Biphenylthio carboxamide is a synthetic compound utilized primarily as a drug intermediate in pharmaceutical synthesis. This compound serves as a critical building block for the development of various bioactive molecules. Its versatility allows for use in diverse applications within medicinal chemistry and drug discovery. -
Drug Impurity
Rebamipide impurity 2 is a chemical impurity associated with Rebamipide. It serves as a reference standard for quality control and the assessment of purity in pharmaceutical formulations. This reagent is critical for researchers conducting studies related to the synthesis and characterization of Rebamipide, facilitating accurate analytics in drug development and regulatory compliance. -
Drug Impurity
Lipoic acid impurity 1 is a chemical byproduct associated with Lipoic acid. Its characterization is critical for quality control in pharmaceutical formulations. As a drug impurity, it is studied for its potential effects on the efficacy and safety profiles of lipoic acid-based therapies. This compound plays a role in ensuring regulatory compliance and optimizing therapeutic strategies in research applications. -
Drug Impurity
Azilsartan impurity 25 is characterized as a drug impurity of Azilsartan, an angiotensin II receptor antagonist. This impurity may serve as a key reference standard in the assessment of Azilsartan's purity and can be utilized in method development and validation during pharmaceutical research. It is essential for ensuring compliance with regulatory standards in drug formulation and quality control. -
Drug Impurity
Ondansetron impurity 5 is a structural impurity of the antiemetic agent Ondansetron. Its characterization is critical for pharmacological and toxicological studies, ensuring the safety and efficacy profiles of Ondansetron formulations. This compound serves as a reference standard in quality control and analytical research, facilitating the assessment of drug purity and compliance with regulatory standards. -
Drug Impurity
Trimetazidine impurity 4 is a known impurity associated with the antiischemic agent Trimetazidine. This compound serves as a reference standard for the analysis of pharmaceutical formulations and quality control processes. Its identification and quantification are essential for ensuring the purity of Trimetazidine in drug development and regulatory compliance. -
Drug Intermediate
(1R,3R)-3-Benzoic acid 3-carboxycyclopentyl ester serves as a critical drug intermediate with applications in the synthesis of various pharmaceuticals. Its structure facilitates the development of bioactive compounds by providing a unique bicyclic framework. This reagent supports research in medicinal chemistry, particularly in the design and assembly of complex organic molecules. -
Drug Impurity
Sildenafil impurity 8 is a chemical impurity associated with the synthesis of Sildenafil, a potent phosphodiesterase type 5 (PDE5) inhibitor. This impurity is utilized in analytical research to ensure the quality and purity of Sildenafil formulations. Its identification and quantification are essential for regulatory compliance and therapeutic efficacy assessments in pharmaceutical development. -
Drug Impurity
Linagliptin impurity 9 is a recognized impurity associated with the DPP-4 inhibitor Linagliptin. This compound serves as a critical reference standard for analytical methods in quality control and stability testing of Linagliptin formulations. Its identification and quantification are essential for ensuring the purity and safety of pharmaceutical products. -
Drug Impurity
Montelukast Impurity 9 is a characterized impurity of Montelukast, a leukotriene receptor antagonist. This compound is utilized primarily in research settings to assess the purity and quality of Montelukast formulations. Its presence can impact the pharmacological effectiveness and safety profile of the primary drug, making it essential for analytical studies and drug development processes. -
Drug Impurity
Trazodone impurity 4 is a known impurity of the antidepressant Trazodone. This compound serves as a vital analytical standard for evaluating the purity and quality of Trazodone formulations. It is utilized in pharmaceutical research, quality control, and method development to ensure compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Progesterone impurity D is characterized as an impurity of the steroid hormone progesterone. This compound is relevant in the assessment of drug quality and purity in pharmaceutical formulations containing progesterone. Its presence may affect the overall efficacy and safety profile of hormone-related therapies, making it important for quality control in research and development settings. -
Drug Impurity
Bortezomib impurity 12 is a known impurity of the proteasome inhibitor Bortezomib, which targets the 26S proteasome and plays a crucial role in the degradation of ubiquitinated proteins. This compound is significant in pharmaceutical research for assessing the purity and quality of Bortezomib formulations, ensuring compliance with regulatory standards. Its presence is critical in understanding the safety and efficacy profiles of drug products containing Bortezomib. -
Drug Impurity
Paliperidone impurity 9 hydrochloride is a chemical byproduct associated with Paliperidone hydrochloride, which primarily acts as an atypical antipsychotic agent targeting dopamine D2 receptors. This impurity is relevant for analytical chemistry and pharmacological development, particularly in ensuring the purity and quality of Paliperidone formulations. Research applications include stability studies, method validation, and toxicological assessments related to pharmaceutical compounds. -
Drug Impurity
Mesalazine impurity 4 is a chemical impurity associated with Mesalazine, a drug primarily used in the treatment of inflammatory bowel disease. This impurity serves as a critical reference standard for quality control and analytical purposes in pharmaceutical research. Its presence in formulations can influence efficacy and safety profiles, making it essential for thorough analytical studies on Mesalazine and related compounds. -
Drug Impurity
Trazodone impurity 5 is a known impurity associated with the antidepressant Trazodone. This compound serves as a standard reference for pharmaceutical quality control, enabling the assessment of purity and verification of synthesis processes. Its identification and quantification are essential for ensuring compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Atenolol impurity 10 is a known impurity of the beta-adrenergic blocker Atenolol. This compound serves as an important tool for quality control and analytical studies, aiding in the assessment of drug purity and stability. Its presence can influence pharmacokinetics and dosing regimens, making it valuable in pharmaceutical development and regulatory compliance assessments. Researchers can utilize this impurity for method validation and impurity profiling in Atenolol formulations. -
Drug Impurity
Methylprednisolone impurity 2 is identified as a chemical impurity associated with Methylprednisolone. This compound serves as an important analytical reference standard in evaluating the purity of Methylprednisolone formulations. It is utilized in various research applications, including pharmacokinetics studies and stability testing, to ensure the quality and safety of pharmaceutical products. -
Drug Impurity
Haloperidol impurity 7, also known as Haloperidol N-oxide, is a drug impurity associated with the antipsychotic agent Haloperidol. Its presence may influence both pharmacological activity and safety profiles in various formulations. This compound is primarily analyzed in the context of quality control and regulatory compliance in pharmaceutical research. Additionally, it serves as a reference standard for the identification and quantification of impurities in Haloperidol production.
